Goldenwell Biotech Inc
Save
19.80M
Market cap
–
Current P/E
–
Forward P/E
About
Consumer Defensive
Sector
Packaged Foods
Industry
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company is developing five products, including JI MAI—bovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG 3D active collagen peptide, as well as DNA repair tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.
Similar securities
Based on sector and market capitalization
Report issue